1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Shanghai Kehua Bio-engineering Co., Ltd.

Shanghai Kehua Bio-engineering Co., Ltd.

002022.SZ
Shanghai Kehua Bio-engineering Co., Ltd.CN flagShenzhen Stock Exchange
4.90
CNY
+0.02
- -
2.52BMarket Cap

Total Valuation

Shanghai Kehua Bio-engineering Co., Ltd. carries a market capitalization of 2.52B, placing it among publicly traded companies globally. Its enterprise value stands at 3.57B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.52B
Enterprise Value3.57B

Share Statistics

Shanghai Kehua Bio-engineering Co., Ltd. currently has 514.32M shares outstanding.

Shares Outstanding514.32M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.92, and the price-to-book ratio stands at 1.12.

PE RatioN/A
PS Ratio1.92
PB Ratio1.12
P/TBV Ratio1.20
P/FCF Ratio15.34
P/OCF RatioN/A

Enterprise Valuation

EV / Sales2.17
EV / EBITDAN/A
EV / EBITN/A
EV / FCF15.10

Financial Position

Shanghai Kehua Bio-engineering Co., Ltd. maintains a current ratio of 2.99, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.93, indicating elevated leverage, while an interest coverage ratio of -12.18 demonstrates limited ability to service its debt obligations.

Current Ratio2.99
Quick Ratio0.89
Debt / Equity15.93
Debt / EBITDA-1.66
Interest Coverage-12.18

Financial Efficiency

Return on Equity (ROE)-22.66
Return on Assets (ROA)-12.23
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.15

Taxes

Income Tax6.50M
Effective Tax RateN/A

Stock Price Statistics

Shanghai Kehua Bio-engineering Co., Ltd.'s stock has declined approximately -22.46835% over the past 52 weeks. The 50-day moving average sits at 5.44, while the 200-day moving average is 6.05.

Beta (5Y)N/A
52-Week Price Change-22.46835%
50-Day Moving Average5.44
200-Day Moving Average6.05
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Shanghai Kehua Bio-engineering Co., Ltd. generated 1.64B in revenue and converted that into -721.59M in net income, yielding earnings per share of -1.62. EBITDA reached -370.15M, while operating income came in at -370.15M.

Revenue1.64B
Gross Profit576.63M
Operating Income-370.15M
Pretax Income-826.76M
Net Income-721.59M
EBITDA-370.15M
EBIT-370.15M
Earnings Per Share (EPS)-1.62

Balance Sheet

Shanghai Kehua Bio-engineering Co., Ltd. holds 817.78M in cash and equivalents against 614.93M in total debt, resulting in a net debt position of -289.09M. Total book value stands at 2.82B, with working capital of 1.82B providing operational flexibility.

Cash & Cash Equivalents817.78M
Total Debt614.93M
Net Debt-289.09M
Equity (Book Value)2.82B
Book Value Per Share5.49
Working Capital1.82B

Cash Flow

After subtracting -205.73M in capital expenditures, free cash flow totaled -205.73M - equivalent to -0.40 per share.

Operating Cash FlowN/A
Capital Expenditures-205.73M
Free Cash Flow-205.73M
FCF Per Share-0.40

Margins

Shanghai Kehua Bio-engineering Co., Ltd. operates with a gross margin of 35.07, reflecting its pricing power and cost economics. The operating margin of -22.51 and net profit margin of -43.89 provide insight into operational efficiency.

Gross Margin35.07
Operating Margin-22.51
Pretax Margin-50.28
Profit Margin-43.89
EBITDA Margin-22.51

Dividends & Yields

The company's payout ratio of -2.50 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.05
Dividend YieldN/A
Payout Ratio-2.50
Shareholder Yield20.21
FCF Yield6.52

Stock Splits

Shanghai Kehua Bio-engineering Co., Ltd.'s most recent stock split took place on May 27, 2010 with a 5:6 split ratio.

Last Split Date5/27/2010
Split Ratio5:6

Scores

Shanghai Kehua Bio-engineering Co., Ltd. posts an Altman Z-Score of 2.86, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.86